HOME >> MEDICINE >> NEWS
Other highlights in the October 15 issue of JNCI

Study Confirms Risk Factors for Malignant Melanoma

A new study confirms previous findings that hair color, number of moles on the legs, and history of sunburn are risk factors for malignant melanoma. The study also found that the use of sunbeds and other tanning devices is associated with an increased risk of the disease. Marit Veierd, Ph.D., of the University of Oslo in Norway, and colleagues surveyed 106,379 Norwegian and Swedish women between the ages of 30 and 50 about their personal characteristics and exposures. During an average follow-up of 8.1 years, there were 187 cases of melanoma diagnosed among these women. Melanoma risk was associated with increasing body surface area; the number of large asymmetric moles on the legs; having naturally red hair; the number of sunburns per year during the second, third, and fourth decades of life; and use one or more times per month of artificial tanning lights. The authors also note that the strongest effects of UV exposure on melanoma risk appear to be during adolescence and early adulthood.

Low White Cell Counts May Affect Breast Cancer Outcomes Among African American Women

African American women with early-stage breast cancer have lower baseline white blood cell counts and therefore appear to have delays in doses of adjuvant chemotherapy compared with white women with early-stage breast cancer. The treatment delays may explain racial differences in breast cancer survival, authors of a new study suggest. Dawn Hershman, M.D., of the New York-Presbyterian Hospital in New York, and her colleagues collected information on 73 African American and 126 matched white women, and of these women, 43 white and 93 African American women had undergone adjuvant chemotherapy. They found that African American women had lower white blood cell counts at baseline and after treatment and required a longer treatment duration (19 weeks versus 15 weeks). "This difference in dose intensity may contribute to t
'"/>

Contact: Linda Wang
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
31-Dec-2000


Page: 1 2 3

Related medicine news :

1. Other highlights in the March 16 JNCI
2. Other highlights in the March 2 JNCI
3. Other highlights in the February 2 JNCI
4. Other highlights in the January 19 JNCI
5. Other highlights in the December 15 JNCI
6. Other highlights in the December 1 JNCI
7. Other highlights in the September 15 JNCI
8. Other highlights in the April 21 JNCI
9. Other highlights in the April 7 JNCI
10. Other highlights in the January 7 issue of JNCI
11. Other highlights in the December 3 issue of JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a ... area —Johnson is one of the first doctors to perform the treatment. Orthobiologics ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... ... Comfort Keepers® of San Diego, CA is excited to announce they are ... drive cancer patients to and from their cancer treatments. Comfort Keepers provides quality ... and ongoing independence. Getting to and from medical treatments is one of the ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology:
Cached News: